ConsulTech is partner in the European project HYDROHEAL aimed at improving the treatment of bone fractures with advanced biomaterials

• HYDROHEAL will develop new biomaterials for the treatment of vertebral and alveolar (jaw) bone fractures
• These materials will help reduce the risks of infection and implant rejection, also reducing fracture recovery times

An international consortium led by the Technical University of Valencia (UPV) with ConsulTech as partner has launched HYDROHEAL, a European project whose objective is to transform the treatment of bone fractures, using new advanced and smart biomaterials. These materials will help reduce the risks of infection and implant rejection, also reducing fracture recovery times.
The project, funded by the European Commission with nearly €6.5 million, began in June 2025 and will last four years. Read More…

The EU has published new funding calls – offering exciting opportunities for research- and innovation-driven companies in the healthcare sector. While the current Mission Cancer programme does not focus on therapy development which are relevant for companies, several other calls within the Health domain present greater potential: they address pressing medical challenges and offer substantial support for research and development projects. Particularly noteworthy is that some calls even allow for the funding of clinical studies up to and including Phase II.
This newsletter provides you with a concise overview of the current calls. Please note that these are single-stage application procedures with a submission deadline in September.
We are happy to support you with the scientific and technical drafting of your proposal, partner search, budget planning, and all formal requirements. Feel free to reach out to us – the initial consultation is, of course, free of charge and offers a great opportunity to explore the potential for your company. Read More…